Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Results of the CHAPTER-1 Open- Label Extension Study

被引：0

作者：

Riedl, Marc ^{[1
]}

Anderson, John ^{[2
]}

Arcoleo, Francesco ^{[3
]}

Cancian, Mauro ^{[4
]}

Chapdelaine, Hugo ^{[5
]}

Conlon, Niall ^{[6
,7
]}

Eren, Efrem ^{[8
]}

Gompels, Mark ^{[9
]}

Grigoriadou, Sofia ^{[10
]}

Guarino, Maria ^{[11
]}

Gurugam, Padmalal ^{[12
]}

Kinaciyan, Tamar ^{[13
]}

Magerl, Markus ^{[14
,15
]}

Manning, Michael ^{[16
]}

Stobiecki, Marcin ^{[17
]}

Tarzi, Michael ^{[18
]}

Valerieva, Anna ^{[19
]}

Wedner, H. James ^{[20
]}

Yang, William ^{[21
]}

Zanichelli, Andrea ^{[22
,23
]}

Crabbe, Rafael

Mulders, Susan

Levy, Jonathan ^{[24
]}

Freudensprung, Ulrich ^{[25
]}

Katbeh, Umar ^{[25
]}

Knolle, Jochen ^{[26
]}

Lesage, Anne ^{[27
]}

Lu, Peng ^{[24
]}

Aygoeren-Puersuen, Emel

机构：

[1] Univ Calif La Jolla, La Jolla, CA USA

[2] AllerVie Hlth, Clin Res Ctr Alabama, Birmingham, AL USA

[3] UOC Patol Clin & Immunol, AOR Villa Sofia Cervello, Palermo, Italy

[4] Univ Hosp Padua, Padua, Italy

[5] UQAC, Chicoutimi, PQ, Canada

[6] St Jamess Hosp & Trinity Coll, Dublin, Ireland

[7] Wellcome Trust CRF, Trinity Coll, Dublin, Ireland

[8] Univ Hosp Southampton NHS Fdn Trust, Southampton, England

[9] North Bristol NHS Trust, Bristol, England

[10] Barts Hlth NHS Trust, London, England

[11] Osped Civitanova Marche, Civitanova Marche, Italy

[12] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[13] Med Univ Vienna, Vienna, Austria

[14] Charite, Berlin, Germany

[15] Fraunhofer ITMP Immunol & Allergol, Berlin, Germany

[16] Allergy Asthma & Immunol Associates Ltd, Scottsdale, AZ USA

[17] Jagiellonian Univ Med Coll, Krakow, Poland

[18] Univ Hosp Sussex NHS Fdn Trust, Brighton, England

[19] Med Univ Sofia, Dept Allergol, Sofia, Bulgaria

[20] Washington Univ, Sch Med, Div Allergy & Immunol, St Louis, MO USA

[21] Ottawa Allergy Res Corp, Ottawa, ON, Canada

[22] Univ Milan, Milan, Italy

[23] IRCCS, Policlin San Donato, Milan, Italy

[24] Pharvaris Inc, Lexington, MA USA

[25] Pharvaris GmbH, Zug, Switzerland

[26] JCK Consult, Frankfurt, Germany

[27] GrayMatters Consulting, Schilde, Belgium

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2025年 / 155卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

600

引用

页码：AB194 / AB194

页数：1

共 50 条

[1] LONG-TERM SAFETY AND EFFICACY OF ORAL DEUCRICTIBANT FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS: CHAPTER-1 OPEN-LABEL EXTENSION STUDY
Anderson, J.
Chapdelaine, H.
Magerl, M.
Manning, M.
Riedl, M.
Wedner, H.
Lu, P.
Aygoren-Pursun, E.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S35 - S35
[2] LONG-TERM SAFETY AND EFFICACY WITH GARADACIMAB FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS IN AN OPEN- LABEL EXTENSION STUDY
Anderson, J.
Levy, D.
Sussman, G.
Jacobs, J.
Farkas, H.
Pollen, M.
Feuersenger, H.
Craig, T.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S5 - S5
[3] Efficacy And Safety Of Bradykinin B2 Receptor Antagonism With Oral Deucrictibant In Prophylaxis Of Hereditary Angioedema Attacks: Results Of CHAPTER-1 Phase 2 Trial
Riedl, Marc
Anderson, John
Arcoleo, Francesco
Cancian, Mauro
Chapdelaine, Hugo
Conlon, Niall
Eren, Efrem
Gompels, Mark
Grigoriadou, Sofia
Guarino, Maria
Gurugama, Padmalal
Kinaciyan, Tamar
Magerl, Markus
Manning, Michael
Stobiecki, Marcin
Tarzi, Michael
Valerieva, Anna
Wedner, H. James
Yang, William
Zanichelli, Andrea
Crabbe, Rafael
Mulders, Susan
Royston, Minying
Zhu, Li
Knolle, Jochen
Lesage, Anne
Lu, Peng
Aygoeren-Puersuen, Emel
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB11 - AB11
[4] Efficacy and safety of oral deucrictibant, a bradykinin B2 receptor antagonist, in prophylaxis of hereditary angioedema attacks: Results of CHAPTER-1 phase 2 trial
Gurugama, Padmalal
Anderson, John
Arcoleo, Francesco
Cancian, Mauro
Chapdelaine, Hugo
Conlon, Niall
Eren, Efrem
Gompels, Mark
Grigoriadou, Sofia
Guarino, Maria D.
Kinaciyan, Tamar
Magerl, Markus
Manning, Michael E.
Stobiecki, Marcin
Tarzi, Michael D.
Valerieva, Anna
Wedner, James
Yang, William H.
Zanichelli, Andrea
Crabbe, Rafael
Mulders, Susan
Royston, Minying
Zhu, Li
Knolle, Jochen
Lesage, Anne
Lu, Peng
Riedl, Marc A.
Aygoeren-Puersuen, Emel
CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (10) : 787 - 788
[5] LONG-TERM TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS WITH ORAL DEUCRICTIBANT: RAPIDE-2 EXTENSION STUDY RESULTS
Anderson, J.
Aygoren-Pursun, E.
Chapdelaine, H.
Farkas, H.
Hakl, R.
Valerieva, A.
Giannattasio, G.
Maurer, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S35 - S35
[6] Long-term efficacy and safety of subcutaneous garadacimab for prophylaxis of hereditary angioedema attacks: Results from a multicentre phase 3 study and open-label extension
Magerl, M.
Reshef, A.
Farkas, H.
Li, H. H.
Jacobs, J. S.
Bernstein, J.
Yang, W.
Stroes, E. S.
Ohsawa, I.
Tachdjian, R.
Manning, M. E.
Lumry, W. R.
Saguer, I. Martinez
Aygoeren-Puersuen, E.
Ritchie, B.
Sussman, G. L.
Anderson, J.
Kawahata, K.
Suzuki, Y.
Staubach, P.
Treudler, R.
Feuersenger, H.
Jacobs, I.
Craig, T. J.
ALLERGY, 2023, 78 : 115 - 117
[7] CHAPTER-1 PHASE 2 TRIAL OF ORAL BRADYKININ B2 RECEPTOR ANTAGONIST DEUCRICTIBANT FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS
Wedner, H.
Anderson, J.
Chapdelaine, H.
Magerl, M.
Manning, M.
Riedl, M.
Lu, P.
Aygoren-Pursun, E.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S34 - S34
[8] Efficacy and safety of oral deucrictibant, a Bradykinin b2 receptor antagonist, in prophy-laxis of hereditary angioedema attacks: results of chapter-1 phase 2 trial
Aygoeren-Puersuen, E.
Anderson, J.
Arcoleo, F.
Cancian, M.
Chapdelaine, H.
Conlon, N.
Eren, E.
Gompels, M.
Grigoriadou, S.
Guarino, M. D.
Gurugama, P.
Kinaciyan, T.
Magerl, M.
Manning, M. E.
Stobiecki, M.
Tarzi, M. D.
Valerieva, A.
Wedner, H. J.
Yang, W. H.
Zanichelli, A.
Crabbe, R.
Mulders, S.
Royston, M.
Zhu, L.
Knolle, J.
Lesage, A.
Lu, P.
Riedl, M. A.
ALLERGOLOGIE, 2024, 47 (09)
[9] Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension study
Reshef, Avner
Hsu, Connie
Katelaris, Constance H.
Li, Philip H.
Magerl, Markus
Yamagami, Keiko
Guilarte, Mar
Keith, Paul K.
Bernstein, Jonathan A.
Lawo, John-Philip
Shetty, Harsha
Pollen, Maressa
Wieman, Lolis
Craig, Tim J.
ALLERGY, 2025, 80 (02) : 545 - 556
[10] Long-term efficacy and safety of oral deucrictibant, a bradykinin b2 receptor antagonist, in treatment of hereditary angioedema attacks: Results of the rapide-2 extension study
Aygoeren-Pirsin, E.
Bouillet, L.
Chapdelaine, H.
Farkas, H.
Gobert, D.
Hakl, R.
Lleonart, R.
Reshef, A.
Spadaro, G.
Ka, M. Staevs-
Stobiecki, M.
Valerieva, A.
Sun, J.
Zhu, L.
Yu, M.
Nattasio, G. Gian-
Lu, P.
Maurer, M.
ALLERGOLOGIE, 2024, 47 (09)

← 1 2 3 4 5 →